logo

Aptose Biosciences Inc (APTO)



Trade APTO now with
  Date
  Headline
10/19/2020 7:13:11 AM Aptose Biosciences Begins Dosing Of CG-806 In Patients With Acute Myeloid Leukemia
6/29/2020 7:24:06 AM Aptose Announces FDA Allowance Of IND For Phase 1a/b Study Of CG-806 In Acute Myeloid Leukemia